Literature DB >> 27062018

Platelet rich plasma in ocular surface.

A C Riestra1, J M Alonso-Herreros2, J Merayo-Lloves3.   

Abstract

The use of platelet-rich preparations has experienced a significant increase in recent years due to its role in tissue-repair and regeneration. The aim of this study is to examine the available evidence regarding the application of plasma rich in growth factors, and its variations, on the ocular surface. A review is also presented on the effects of platelet-derived growth factors, the implications of the preparation methods, and the existing literature on the safety and efficacy of these therapies in ocular surface diseases. Despite the widespread use of platelet preparations there is no consensus on the most appropriate preparation method, and growth factors concentration vary with different systems. These preparations have been used in the treatment of ocular surface diseases, such as dry eye or persistent epithelial defects, among others, with good safety and efficacy profiles, but further studies are needed to compare to the currently available alternatives.
Copyright © 2016 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Blood products; Cornea; Córnea; Derivados hemáticos; Ocular surface; Plasma rich in growth factors; Plasma rico en factores de crecimiento; Plasma rico en plaquetas; Platelet rich plasma; Superficie ocular

Mesh:

Year:  2016        PMID: 27062018     DOI: 10.1016/j.oftal.2016.03.001

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  6 in total

Review 1.  Regenerative Therapies in Dry Eye Disease: From Growth Factors to Cell Therapy.

Authors:  Antonio J Villatoro; Viviana Fernández; Silvia Claros; Cristina Alcoholado; Manuel Cifuentes; Jesús Merayo-Lloves; José A Andrades; José Becerra
Journal:  Int J Mol Sci       Date:  2017-10-28       Impact factor: 5.923

2.  Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders.

Authors:  Ronald M Sanchez-Avila; Jesús Merayo-Lloves; Ana C Riestra; Silvia Berisa; Carlos Lisa; José Alfonso Sánchez; Francisco Muruzabal; Gorka Orive; Eduardo Anitua
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

3.  Plasma Rich in Growth Factors in Macular Hole Surgery.

Authors:  Ronald M Sánchez-Ávila; Carlos A Robayo-Esper; Eva Villota-Deleu; Álvaro Fernández-Vega Sanz; Álvaro Fernández-Vega González; Borja de la Sen-Corcuera; Eduardo Anitua; Jesús Merayo-Lloves
Journal:  Clin Pract       Date:  2022-01-10

4.  Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum.

Authors:  Eduardo Anitua; Francisco Muruzabal; Ander Pino; Roberto Prado; Mikel Azkargorta; Felix Elortza; Jesús Merayo-Lloves
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

5.  Differential Protein Content between Fresh and Freeze-Dried Plasma Rich in Growth Factors Eye Drops.

Authors:  Eduardo Anitua; Ander Pino; Mikel Azkargorta; Felix Elortza; Jesús Merayo-Lloves; Francisco Muruzabal
Journal:  Biomolecules       Date:  2022-09-01

6.  Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma.

Authors:  Ronald M Sánchez-Avila; Jesus Merayo-Lloves; Maria Laura Fernández; Luis Alberto Rodríguez-Gutiérrez; Pedro Pablo Rodríguez-Calvo; Andres Fernández-Vega Cueto; Francisco Muruzabal; Gorka Orive; Eduardo Anitua
Journal:  Int Med Case Rep J       Date:  2018-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.